Commonly studied inflammatory markers such as CRP, IL-6, TNF-α, and procalcitonin (PCT) have all been associated with cancer-related inflammation [101] CRP, for instance, is recognized as a prognostic marker in multiple malignancies, including pancreatic, breast, gastrointestinal, and renal cancers [102,103]. This evidence concerns the gene IL6 and cancer.